MAST: a hybrid Multi-Agent Spatio-Temporal model of tumor microenvironment informed using a data-driven approach.


Journal

Bioinformatics advances
ISSN: 2635-0041
Titre abrégé: Bioinform Adv
Pays: England
ID NLM: 9918282081306676

Informations de publication

Date de publication:
2022
Historique:
received: 03 11 2022
accepted: 03 12 2022
entrez: 26 1 2023
pubmed: 27 1 2023
medline: 27 1 2023
Statut: epublish

Résumé

Recently, several computational modeling approaches, such as agent-based models, have been applied to study the interaction dynamics between immune and tumor cells in human cancer. However, each tumor is characterized by a specific and unique tumor microenvironment, emphasizing the need for specialized and personalized studies of each cancer scenario. We present MAST, a hybrid Multi-Agent Spatio-Temporal model which can be informed using a data-driven approach to simulate unique tumor subtypes and tumor-immune dynamics starting from high-throughput sequencing data. It captures essential components of the tumor microenvironment by coupling a discrete agent-based model with a continuous partial differential equations-based model.The application to real data of human colorectal cancer tissue investigating the spatio-temporal evolution and emergent properties of four simulated human colorectal cancer subtypes, along with their agreement with current biological knowledge of tumors and clinical outcome endpoints in a patient cohort, endorse the validity of our approach. MAST, implemented in Python language, is freely available with an open-source license through GitLab (https://gitlab.com/sysbiobig/mast), and a Docker image is provided to ease its deployment. The submitted software version and test data are available in Zenodo at https://dx.doi.org/10.5281/zenodo.7267745. Supplementary data are available at

Identifiants

pubmed: 36699399
doi: 10.1093/bioadv/vbac092
pii: vbac092
pmc: PMC9744439
doi:

Types de publication

Journal Article

Langues

eng

Pagination

vbac092

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

Mol Cancer. 2019 Mar 30;18(1):67
pubmed: 30927930
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Biophys Rev. 2021 Feb 11;13(2):185-202
pubmed: 34290841
Cancers (Basel). 2021 Mar 19;13(6):
pubmed: 33808627
Nat Rev Cancer. 2020 Jun;20(6):343-354
pubmed: 32341552
Genes (Basel). 2018 Nov 28;9(12):
pubmed: 30487452
Clin Cancer Res. 2015 Nov 15;21(22):5047-56
pubmed: 26567364
Clin Cancer Res. 2016 Dec 1;22(23):5642-5650
pubmed: 27698000
J Autoimmun. 2019 Nov;104:102333
pubmed: 31564474
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10985-90
pubmed: 16832064
Elife. 2017 Nov 13;6:
pubmed: 29130882
Bioinformatics. 2019 Jul 15;35(14):i436-i445
pubmed: 31510660
Cancer Res. 2017 Nov 15;77(22):6442-6452
pubmed: 28923860
J R Soc Interface. 2017 Sep;14(134):
pubmed: 28931635
Bioinformatics. 2022 Jan 19;:
pubmed: 35043939
J Pharmacokinet Pharmacodyn. 2014 Oct;41(5):389-99
pubmed: 25238901
Genome Med. 2019 May 24;11(1):34
pubmed: 31126321
PLoS One. 2018 Mar 2;13(3):e0193498
pubmed: 29499048
Sci Rep. 2016 Sep 23;6:33322
pubmed: 27659691
J Biomed Opt. 2017 Sep 1;22(9):91506
pubmed: 28241323
Cell Death Dis. 2020 Nov 26;11(11):1013
pubmed: 33243969
Bioinformatics. 2009 Sep 15;25(18):2389-96
pubmed: 19578172
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Nat Genet. 2020 Jun;52(6):594-603
pubmed: 32451460
Proc Natl Acad Sci U S A. 2002 May 14;99 Suppl 3:7280-7
pubmed: 12011407
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Nature. 2009 Apr 9;458(7239):719-24
pubmed: 19360079
Crit Rev Biochem Mol Biol. 2019 Jun;54(3):193-207
pubmed: 31162937
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Cancer Res. 2016 Oct 15;76(20):5921-5925
pubmed: 27694601
Front Pharmacol. 2019 Feb 28;10:139
pubmed: 30873025
Int Immunopharmacol. 2020 Sep;86:106700
pubmed: 32590316
J Theor Biol. 2018 Sep 7;452:56-68
pubmed: 29750999
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Semin Cancer Biol. 2018 Oct;52(Pt 2):189-197
pubmed: 29501787
J Exp Med. 2000 Feb 7;191(3):423-34
pubmed: 10662788
Front Immunol. 2019 Apr 30;10:924
pubmed: 31134058
Eur J Cancer. 2016 Nov;68:134-147
pubmed: 27755997
Front Aging. 2022 Jan 03;2:800380
pubmed: 35822012
Clin Cancer Res. 2015 Feb 15;21(4):687-92
pubmed: 25501578
J Clin Invest. 2008 Apr;118(4):1390-7
pubmed: 18357341
Math Med Biol. 2017 Jun 1;34(2):215-240
pubmed: 27094601
Processes (Basel). 2019 Jan;7(1):
pubmed: 30701168

Auteurs

Giulia Cesaro (G)

Department of Information Engineering, University of Padova, 35131 Padova, Italy.

Mikele Milia (M)

Department of Information Engineering, University of Padova, 35131 Padova, Italy.

Giacomo Baruzzo (G)

Department of Information Engineering, University of Padova, 35131 Padova, Italy.

Giovanni Finco (G)

Department of Information Engineering, University of Padova, 35131 Padova, Italy.

Francesco Morandini (F)

Department of Information Engineering, University of Padova, 35131 Padova, Italy.

Alessio Lazzarini (A)

Department of Information Engineering, University of Padova, 35131 Padova, Italy.

Piergiorgio Alotto (P)

Department of Industrial Engineering, University of Padova, 35131 Padova, Italy.

Noel Filipe da Cunha Carvalho de Miranda (NF)

Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Zlatko Trajanoski (Z)

Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Francesca Finotello (F)

Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Institute of Molecular Biology, University Innsbruck, 6020 Innsbruck, Austria.
Digital Science Center (DiSC), University Innsbruck, 6020 Innsbruck, Austria.

Barbara Di Camillo (B)

Department of Information Engineering, University of Padova, 35131 Padova, Italy.
Department of Comparative Biomedicine and Food Science, University of Padova, 35020 Padova, Italy.

Classifications MeSH